This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

£200 Savings Ends In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
4 - 6 June, 2024
Excel London Platinum Suite

Stefan Zielonka, PhD
Global Head of Antibody Discovery and Protein Engineering at Merck Healthcare KGaA
Speaker

Profile

Stefan received his PhD in chemistry from Technische Universität Darmstadt in 2015. At moment he works as Senior Director and Global Head of Antibody Discovery & Protein Engineering at Merck Healthcare KGaA as well as Professor of Biomolecular Immunotherapy at Technische Universität Darmstadt. Stefan holds a habilitation in Biochemistry.

Agenda Sessions

  • Generation, Engineering and De Novo High-throughput Humanization of VHH-derived Multispecifics for Immune Cell Activation

    08:20